PATENT CLAIM ANALYSIS

Application Number: 15917919
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "049000"]

Abstract:
An embodiment of the present disclosure provides a composition that comprises hyaluronic acid, or its salt or derivative thereof, and an antimicrobial agent, such as zinc citrate, that does not degrade the hyaluronic acid molecule.

Claim (Index 6):
The method of  claim 1 , wherein the molecular weight of the solution is not substantially reduced over about 6 months as measured by rheologic viscosity in Centipoise.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.25
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14995325', '13874031', '13874077', '13683001', '12809809']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7328865657025151
- 35 USC 102 Novelty (BERT): 0.5726431026704206
- Combined Prediction Score: 0.7168622193993056
- Mean Citation Score: 330.23691799999995
- Max Citation Score: 439.134
- Similarity Product: 412.3960385277271

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test